MAPT and Alzheimer disease: Interestingly, sevoflurane has been shown to promote AD-associated apoptosis, Tau protein phosphorylation10-11, and β-amyloid protein accumulation (Aβ)9, the major pathological hallmarks of AD neuropathogenesis, in cultured cells and in animals.